Sean Bohen, PRESIDENT AND CEO at Olema Pharmaceuticals, Inc. (OLMA), sold 1,085 shares at $30.07 ($33K) on 2021-09-27, disclosed to the SEC on 2021-09-29.
Scheduled sale ($33k) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| OLMA | SELL | 2021-10-15 | $294K | — | Filing → |
| OLMA | SELL | 2021-09-09 | $91K | — | Filing → |
| OLMA | SELL | 2021-09-03 | $26K | — | Filing → |